Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Alivus Life Sciences Ltd

NSE: ALIVUS

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Alivus Life Sciences Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 15,353.8 Cr.
Price in snapshot: ₹ 1,250.6
ROE: 18.34 %
ROCE: 23.05 %
Dividend Yield: 0.4 %

Snapshot updated 18 October 2026. Figures are not live quotes.

Research coverage

Concall documents: presentation for Q2 FY27, dated 29 October 2026.
Annual-report coverage: FY2025.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings